Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial127

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial39

Views

Views
October 20253
November 20257
December 20254
January 202612
February 20260
March 202613
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States20
Brazil7
Finland5
United Kingdom2
United Arab Emirates1
Argentina1
France1
Singapore1
Tunisia1
 

Top cities views

Views
Ashburn7
Helsinki5
San Jose3
Campos dos Goytacazes2
Belo Horizonte1
Belém1
Cleveland1
Los Angeles1
Rio das Pedras1
San Luis1